In cases where the clinical picture alone is insufficient to guide treatment, CT plaque analysis serves as a powerful tie-breaker — moving the decision from population-level risk estimates to a direct assessment of what is occurring inside an individual patient's arteries.



When results reveal no significant plaque, this provides objective evidence that the patient's arterial health is better than their risk factors alone might suggest. This finding can reasonably support a decision to defer or withhold statin therapy, while offering meaningful reassurance to both the patient and their clinician. 

Conversely, when results demonstrate a high plaque burden or high-risk plaque features, this confirms that atherosclerotic disease is already silently progressing — even in the absence of symptoms. Such findings justify initiating or intensifying statin therapy and often prompt a broader, more aggressive approach to cardiovascular risk factor management.

It is within this decision-making framework that the clinical indications for CT plaque analysis are best understood.



CT plaque analysis (typically performed as part of coronary CT angiography (CCTA) with plaque characterization) is indicated in the following clinical scenarios:

This is critically important because:

The plaques most likely to cause a heart attack are often the soft, non-calcified ones — not the hard, calcified ones

Calcified plaque is more stable in many cases. It's the soft, lipid-rich plaques that are prone to rupturing, triggering a clot, and causing an acute myocardial infarction.

High-Risk Plaque Detection

Identifying vulnerable/high-risk plaque features that predict future acute coronary syndrome (ACS), such as:

• Low-attenuation plaque (lipid-rich necrotic core)
• Positive remodeling
• Napkin-ring sign
• Spotty calcification
  

Contraindications to Consider

CT plaque analysis is generally not indicated in:

• Patients with known obstructive CAD (invasive coronary angiography preferred)
• Very high or very low pre-test probability (low diagnostic yield)
• Severe renal impairment (contrast contraindicated)
• Significant arrhythmia (poor image quality)
• Inability to achieve adequate heart rate control
  

A Simple Analogy

Think of coronary arteries like a pipe:

• A CAC score is like checking if there is rust (calcium) visible on the outside of the pipe
• CT plaque analysis is like doing a full internal inspection - checking for rust, soft buildup, weak spots, and areas about to crack



The CAC score tells you something is there. CT plaque analysis tells you what it is, how dangerous it is, and where exactly the risk lies. CT plaque analysis is the step up when you need to truly understand the nature and danger of what is building up inside a patient's coronary arteries.

A 58-year-old man, no symptoms, has high cholesterol, is borderline hypertensive, and smokes occasionally. His ASCVD score comes back at 14% - intermediate risk.



Should he start a statin?

On paper, it's unclear. But if a CT plaque analysis reveals:

• Heavyplaque burden with low-attenuation (vulnerable) plaques → Start statin, possibly refer to cardiology
• No plaque detected → May defer statin, focus on lifestyle, recheck in a tew years
  

Note: Guidelines from the ACC/AHA, ESC, and SCCT continue to evolve regarding optimal patient selection. Shared decision-making between clinician and patient is central to appropriate ordering, particularly for asymptomatic individuals.